Literature DB >> 16796374

Drug discovery from natural sources.

Young-Won Chin1, Marcy J Balunas, Hee Byung Chai, A Douglas Kinghorn.   

Abstract

Organic compounds from terrestrial and marine organisms have extensive past and present use in the treatment of many diseases and serve as compounds of interest both in their natural form and as templates for synthetic modification. Over 20 new drugs launched on the market between 2000 and 2005, originating from terrestrial plants, terrestrial microorganisms, marine organisms, and terrestrial vertebrates and invertebrates, are described. These approved substances, representative of very wide chemical diversity, together with several other natural products or their analogs undergoing clinical trials, continue to demonstrate the importance of compounds from natural sources in modern drug discovery efforts.

Mesh:

Substances:

Year:  2006        PMID: 16796374      PMCID: PMC3231566          DOI: 10.1007/bf02854894

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  109 in total

Review 1.  Natural products as sources of new drugs over the period 1981-2002.

Authors:  David J Newman; Gordon M Cragg; Kenneth M Snader
Journal:  J Nat Prod       Date:  2003-07       Impact factor: 4.050

2.  FUNGAL METABOLITES. THE STRUCTURES OF THE NOVEL SESQUITERPENOIDS ILLUDIN-S AND -M.

Authors:  T C MCMORRIS; M ANCHEL
Journal:  J Am Chem Soc       Date:  1965-04-05       Impact factor: 15.419

3.  Geldanamycin. I. Structure assignment.

Authors:  K Sasaki; K L Rinehart; G Slomp; M F Grostic; E C Olson
Journal:  J Am Chem Soc       Date:  1970-12-30       Impact factor: 15.419

Review 4.  Guidance on the use of miglustat for treating patients with type 1 Gaucher disease.

Authors:  Neal J Weinreb; John A Barranger; Joel Charrow; Gregory A Grabowski; Henry J Mankin; Pramod Mistry
Journal:  Am J Hematol       Date:  2005-11       Impact factor: 10.047

5.  Exenatide.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 6.  Micafungin.

Authors:  Blair Jarvis; David P Figgitt; Lesley J Scott
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 7.  Galanthamine from snowdrop--the development of a modern drug against Alzheimer's disease from local Caucasian knowledge.

Authors:  Michael Heinrich; Hooi Lee Teoh
Journal:  J Ethnopharmacol       Date:  2004-06       Impact factor: 4.360

8.  Phase I clinical trial and pharmacokinetic study of the spicamycin analog KRN5500 administered as a 1-hour intravenous infusion for five consecutive days to patients with refractory solid tumors.

Authors:  Jeffrey G Supko; Joseph P Eder; David P Ryan; Michael V Seiden; Thomas J Lynch; Phillip C Amrein; Donald W Kufe; Jeffrey W Clark
Journal:  Clin Cancer Res       Date:  2003-11-01       Impact factor: 12.531

Review 9.  Rosuvastatin: a review of its use in the management of dyslipidemia.

Authors:  Lesley J Scott; Monique P Curran; David P Figgitt
Journal:  Am J Cardiovasc Drugs       Date:  2004       Impact factor: 3.571

10.  Pharmacodynamic response and inhibition of growth of human tumor xenografts by the novel histone deacetylase inhibitor PXD101.

Authors:  Jane A Plumb; Paul W Finn; Robert J Williams; Morwenna J Bandara; M Rosario Romero; Claire J Watkins; Nicholas B La Thangue; Robert Brown
Journal:  Mol Cancer Ther       Date:  2003-08       Impact factor: 6.261

View more
  126 in total

1.  Methanolic Fractions of Ornithogalum cuspidatum Induce Apoptosis in PC-3 Prostate Cancer Cell Line and WEHI-164 Fibrosarcoma Cancer Cell Line.

Authors:  Hamed Asadi; Mona Orangi; Dariush Shanehbandi; Zohreh Babaloo; Abbas Delazar; Leila Mohammadnejad; Fatemeh Zare Shahneh; Samira Valiyari; Behzad Baradaran
Journal:  Adv Pharm Bull       Date:  2014-08-25

2.  Macroevolution of venom apparatus innovations in auger snails (Gastropoda; Conoidea; Terebridae).

Authors:  M Castelin; N Puillandre; Yu I Kantor; M V Modica; Y Terryn; C Cruaud; P Bouchet; M Holford
Journal:  Mol Phylogenet Evol       Date:  2012-03-14       Impact factor: 4.286

3.  Current trends in the chemoprevention of cancer.

Authors:  Fazlul H Sarkar
Journal:  Pharm Res       Date:  2010-04-17       Impact factor: 4.200

4.  Lipophilic mediated assays for beta-hematin inhibitors.

Authors:  Melissa D Carter; Vanessa V Phelan; Rebecca D Sandlin; Brian O Bachmann; David W Wright
Journal:  Comb Chem High Throughput Screen       Date:  2010-03       Impact factor: 1.339

Review 5.  A functional approach to transcriptome profiling: linking gene expression patterns to metabolites that matter.

Authors:  Cindi A Hoover; Marc Slattery; Adam G Marsh
Journal:  Mar Biotechnol (NY)       Date:  2007-05-01       Impact factor: 3.619

6.  Engineering central metabolic pathways for high-level flavonoid production in Escherichia coli.

Authors:  Effendi Leonard; Kok-Hong Lim; Phan-Nee Saw; Mattheos A G Koffas
Journal:  Appl Environ Microbiol       Date:  2007-04-27       Impact factor: 4.792

7.  Negundoside, an irridiod glycoside from leaves of Vitex negundo, protects human liver cells against calcium-mediated toxicity induced by carbon tetrachloride.

Authors:  Sheikh A Tasduq; Peerzada J Kaiser; Bishan D Gupta; Vijay K Gupta; Rakesh K Johri
Journal:  World J Gastroenterol       Date:  2008-06-21       Impact factor: 5.742

8.  Crystal structure determination of new antimitotic agent bis(p-fluorobenzyl)trisulfide.

Authors:  Haoyun An; Xiurong Hu; Jianming Gu; Linshen Chen; Weiming Xu; Xiaopeng Mo; Wanhong Xu; Xiaobo Wang; Xiao Xu
Journal:  AAPS PharmSciTech       Date:  2008-04-22       Impact factor: 3.246

9.  Identifying a resistance determinant for the antimitotic natural products disorazole C1 and A1.

Authors:  John S Lazo; Celeste E Reese; Andreas Vogt; Laura L Vollmer; Carolyn A Kitchens; Eckhard Günther; Thomas H Graham; Chad D Hopkins; Peter Wipf
Journal:  J Pharmacol Exp Ther       Date:  2009-12-15       Impact factor: 4.030

10.  Enantioselective synthesis of pactamycin, a complex antitumor antibiotic.

Authors:  Justin T Malinowski; Robert J Sharpe; Jeffrey S Johnson
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.